Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Mallinckrodt
Deloitte
McKinsey
Chubb
Fish and Richardson
Fuji
Healthtrust
Daiichi Sankyo

Generated: September 23, 2018

DrugPatentWatch Database Preview

Biologic Drugs With Dosage Form: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

« Back to Dashboard

Details for Dosage Type: INJECTABLE;INTRAVENOUS, SUBCUTANEOUS

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Warsaw Orthopedic, Inc. ( ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Warsaw Orthopedic, Inc. ( ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Aegis Therapeutics LLC (San Diego, CA) ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Merck Sharp & Dohme Corp. (Rahway, NJ) ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Genentech, Inc. (South San Francisco, CA) Hoffmann-La Roche Inc. (Nutley, NJ) ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up Synovex Corporation (Medford, MA) ➤ Sign Up RX search
Genentech ACTEMRA tocilizumab INJECTABLE;INTRAVENOUS, SUBCUTANEOUS 125472 001 2013-10-21 ➤ Sign Up University of Maryland, Baltimore (Baltimore, MD) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Moodys
Federal Trade Commission
Daiichi Sankyo
UBS
Teva
Mallinckrodt
Queensland Health
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.